<DOC>
	<DOCNO>NCT02306720</DOCNO>
	<brief_summary>To collect evaluate long-term safety effectiveness data HPP patient have/ receive treatment asfotase alfa .</brief_summary>
	<brief_title>An Observational , Longitudinal , Prospective , Long-Term Registry Of Patients With Hypophosphatasia ( HPP )</brief_title>
	<detailed_description>To collect evaluate long-term safety effectiveness data HPP patient have/ receive treatment asfotase alfa .</detailed_description>
	<mesh_term>Hypophosphatasia</mesh_term>
	<criteria>Male female patient , age , confirm diagnosis HPP . Patient legal representative able read and/or understand inform consent study questionnaires local language . Signed informed consent medical record release patient legal representative . Patient patient 's parent/legal representative must willing able give write informed consent , patient must willing give write informed assent , appropriate require local regulation . Currently participate Alexionsponsored clinical trial previously receive asfotase alfa . Enrollment Registry exclude patient enrol future clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>